<DOC>
	<DOCNO>NCT00798915</DOCNO>
	<brief_summary>An intestinal hormone call Glucose-dependent Insulinotropic Polypeptide ( GIP ) release blood immediately ingestion meal play important role regulate blood sugar level . However , GIP active person type 2 diabetes mellitus ( T2DM ) also know adult onset non-insulin-dependent diabetes . This study conduct determine whether hormone call xenin-25 restore activity GIP person T2DM .</brief_summary>
	<brief_title>Study Effects Xenin-25 Humans With Without Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Each eligible participant administer oral glucose tolerance test he/she assign group `` normal glucose tolerance '' , `` impair glucose tolerance '' ( normal diabetic ) , type 2 diabetes mellitus . Each study subject administer grade glucose infusion ( GGI ) 4 separate occasion . For GGI , intravenous glucose infusion start rate 1 mg x kg-1 x min-1 40 min , follow 2 , 3 , 4 , 6 , 8 mg x kg-1 x min-1 ( 40 min step ) . A primed-continuous infusion vehicle alone , GIP alone , xenin-25 alone , combination GIP plus xenin-25 ( peptide dose 4 pmoles x kg-1 x min-1 ) initiate time glucose infusion start . Blood sample collect GGI measurement glucose , insulin , C-peptide , glucagon , GIP xenin-25 level .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<criteria>Individuals must able consent participation ( mental impairment affect cognition willingness follow study instruction ) . Healthy volunteer clinical evidence T2DM . Otherwise healthy volunteer impair glucose tolerance . Otherwise healthy volunteer diet control T2DM . Otherwise healthy volunteer T2DM take oral agent subject 's preexist oral antidiabetic agent safely discontinue 48hours . Persons HbA1c le 9 % . Women childbearing potential must currently taking/using acceptable method birth control . A pregnancy test do begin visit . Any woman positive pregnancy test remove study . Willingness complete require visit . Lacks cognitive ability sign consent follow study direction . Women unwilling use acceptable method contraception course study , currently breastfeed . Any subject whose screen HbA1c &gt; 9.0 % . Type 2 diabetes require use supplemental insulin home . Volunteers history Acute Pancreatitis . Volunteers history cancer ( except skin cancer ) . Volunteer history Chronic Pancreatitis and/or risk factor chronic pancreatitis include hypertriglyceridemia ( triglyceride &gt; 400mg/ml ) hypercalcemia ( blood calcium level &gt; 11.md/dl ) and/or presence gallstone . Volunteers history gastrointestinal disorder , particularly relate gastric motility/emptying gastric bypass , document gastroparesis diabetic volunteer . Subjects take medication know affect glucose tolerance . Hematocrit lab 33 % ( finger stick hemoglobin measure HemoCue 201+ &lt; 11.2 % mg/dlL ) . Diabetics potential low blood sugar without aware blood sugar low ( hypoglycemia unawareness ) . Significant systemic illness include heart , kidney , inflammatory , liver , malignant disease require medication . Subjects exclude liver kidney function outside upper limit normal &gt; 3 % . Total Bilirubin level &lt; 2 . Subjects unwilling allow use human albumin preparation peptide . Unwillingness allow blood glucose level adjustment ( need ) IV insulin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Blood Sugar</keyword>
	<keyword>Xenin-25</keyword>
	<keyword>GIP</keyword>
	<keyword>Insulin</keyword>
</DOC>